postoperative bleeding (P ¼ .99), survival (P ¼ .13), primary patency (P ¼ .872), and amputation free survival (P ¼ .99; Table) .
IP145.
Extensive Acute Aortic Intramural Hematoma: Rare Complication Following Cardiopulmonary Resuscitation Suleiman Suda, Khanjan H. Nagarsheth. Rutgers University, New Brunswick, NJ Objectives: Cardiopulmonary resuscitation (CPR) is a lifesaving procedure used to establish return of spontaneous circulation (ROSC) following cardiac arrest. Complications from CPR are common but rarely result in acute aortic intramural hematoma (IMH). We present a case of this rare complication following manual CPR for cardiac arrest.
Methods: Case report and review of the literature.
Results: A 76-year old man arrived to the emergency department with complaints of garbled speech, altered mental status, and facial droop. He was found to have an acute frontoparietal stroke and was managed with blood pressure control and intensive care admission. Within the next few hours, he deteriorated clinically and became progressively hypoxic, resulting in cardiac arrest. He underwent several rounds of CPR and had ROSC. Subsequent to this, a significant pulse differential was noted in his lower extremities. A computed tomography angiogram revealed an extensive IMH from the mid descending thoracic aorta to beyond the level of the renal vessels. His overall prognosis was grim, so no revascularization was performed and his IMH was managed medically with blood pressure and heart rate control. He died 2 days later of complications associated with his stroke and aspiration pneumonitis.
Conclusions: In reviewing the literature, there are scattered case reports of IMH occurring after CPR. Given that IMH of the aorta is a potentially lethal disorder with frequent progression to aortic rupture, dissection, or aneurysm, it is critical to educate physicians about its association with CPR. There is one reported survivor in the literature in a patient who had a focal aortic IMH following CPR and had endovascular treatment. Following stabilization of patients with ROSC, diagnostic measures should be used promptly if IMH is suspected to see whether surgical treatment is possible. Objectives: Despite dramatic improvement in the outcomes of carotid artery stenting (CAS), this procedure continues to have higher postoperative complications rates compared to carotid endarterectomy (CEA). The aim of this study is to quantify the incremental cost associated with postoperative stroke, death, and myocardial infarction (MI) after CAS in comparison to CEA.
Methods: A retrospective analysis of patients who underwent CEA and CAS in Premier Database (467 teaching and nonteaching hospitals) 2009 to 2015 was performed. The primary outcomes included rates of stroke, death, and MI and the incremental actual costs (in USD) associated with these complications. Multivariate logistic models and postestimation marginal effects after generalized linear regression were used.
Results: A total of 100,185 patients were included. Of those, 14,150 (14.1%) underwent CAS and 86,035 underwent CEA (85.9%). Mean age was 70.7 6 9.5 years. Most patients were men (58.3%), white (82.1%), and had Medicare insurance (74.7%). Compared to CEA, CAS had higher stroke (2.6% vs 1.4%; P < .001) and death (1.4% vs 0.4%; P < .001) but similar MI rates (0.8% vs 0.7%; P ¼ .05). After risk adjustment, CAS had 55% higher risk of stroke (adjusted odds ratio, 1.55; 95% confidence interval [CI], 1.36-1.77; P < .001) and 2.6 higher odds of death (adjusted odds ratio, 2.60l; 95% CI, 2.14-3.17; P < .001) compared to CEA. Risk factors associated with increase stroke or death, are described in Table I . The adjusted incremental cost (aIC) of stroke, death, and MI was higher in CEA than CAS and in asymptomatic vs symptomatic patients. For example, a stroke in an asymptomatic patient following CEA had 59.8% increase in aIC from baseline cost ($5273; 95% CI, $4691-45854) compared to 26.2% increase ($3090; 95% CI, $1970-$4210) following CAS, while an MI in a symptomatic patient following CEA had 38.9% increase in aIC ($4383; 95% CI, $2081-$6685) compared with a 6.4% increase ($912; 95% CI, e$4328 to $6153) following CAS. The same complication had a higher incremental cost if it occurred in asymptomatic patients compared to their symptomatic counterparts within each procedure (Table II) .
Conclusions: Compared to CAS, CEA is known to be a more cost-effective carotid intervention since it has fewer complications and a lower baseline cost. However, the incremental cost of stroke, death, and MI after this procedure is significantly higher than CAS, especially in asymptomatic patients. This might be due to increased severity and weight of these complications when they occur after CEA and in asymptomatic patients. These findings are important when considering long-term cost-effectiveness and quality improvement interventions. HR, Hazard ratio; LCL, lower confidence limit; UCL, upper confidence limit. 
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